Spinal Tech

Here are eight key notes from orthopedic and spine device companies in the past week.

Johnson & Johnson reported orthopedics sales decreased 1 percent in the fourth quarter of 2018 to $2.2 billion; for the full year, orthopedic sales dipped 1.9 percent to $8.8 billion.

European private equity firm Nordic Capital acquired majority holding in Orchid Orthopedic Solutions from Altor Fund III.

Johnson & Johnson reported fourth quarter and full-year results for DePuy Synthes, its orthopedics division.

Zimmer Biomet partnered with construction solutions company Profica, according to Engineering News.

It is estimated that 15 percent of joint replacements will fail, which can require revision surgeries.

Osseus Fusion Systems is a spine device company.

Anterior cervical discectomy and fusion procedures are widely common and used to treat degenerative disorders.

John A. Hatheway, MD, of Spokane, Wash., enrolled the first patient in the clinical study to evaluate Medtronic's SynchroMed II Intrathecal drug delivery system for patients with primary back pain.

Moody's expects robotics to continue expanding in orthopedics and spine, according to the firm's Healthcare Quarterly.